Phillip G. Febbo

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Real-world analysis of primary tumor transcriptomes in patients subsequently treated with PARP inhibitors.

  Journal of Clinical Oncology · 2025-05-28

• Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer

  European Urology Oncology · 2025-05-10 · 2 citations

• MP10-10 MOLECULAR FEATURES OF GRADE GROUP 1 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

  The Journal of Urology · 2025-04-08

• IP05-02 RISK STRATIFICATION USING THE DECIPHER 22-GENE GENOMIC CLASSIFIER (GC) AND DIGITAL PATHOLOGY ARTIFICIAL INTELLIGENCE (DPAI) IN NEARLY 10,000 LOCALIZED PROSTATE CANCER PATIENTS

  The Journal of Urology · 2025-04-08

• IP05-05 REGIONAL PROSTATE CANCER TRANSCRIPTOMIC HETEROGENEITY OBSERVED IN A COMPARATIVE ANALYSIS WITH A A NATIONAL COHORT

  The Journal of Urology · 2025-04-08

• Editor’s Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells

  Cancer Research · 2024-08-01